Rituxan SC (rituximab)

pCPA File Number: 21048
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic lymphocytic leukemia
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: